|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7-8
|
|
pubmed:dateCreated |
2010-7-1
|
|
pubmed:abstractText |
Most literature available for unfractionated heparin (UFH) supports the use of actual body weight for dosing all patients, yet a small proportion of the patients in these studies were morbidly obese. The most appropriate dosing strategy for therapeutic UFH in this patient population is not clearly defined.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1542-6270
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
44
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1141-51
|
|
pubmed:dateRevised |
2010-12-22
|
|
pubmed:meshHeading |
pubmed-meshheading:20587743-Adult,
pubmed-meshheading:20587743-Aged,
pubmed-meshheading:20587743-Aged, 80 and over,
pubmed-meshheading:20587743-Anticoagulants,
pubmed-meshheading:20587743-Body Weight,
pubmed-meshheading:20587743-Cohort Studies,
pubmed-meshheading:20587743-Dose-Response Relationship, Drug,
pubmed-meshheading:20587743-Female,
pubmed-meshheading:20587743-Hemorrhage,
pubmed-meshheading:20587743-Heparin,
pubmed-meshheading:20587743-Humans,
pubmed-meshheading:20587743-Infusions, Intravenous,
pubmed-meshheading:20587743-Male,
pubmed-meshheading:20587743-Middle Aged,
pubmed-meshheading:20587743-Nomograms,
pubmed-meshheading:20587743-Obesity,
pubmed-meshheading:20587743-Obesity, Morbid,
pubmed-meshheading:20587743-Partial Thromboplastin Time,
pubmed-meshheading:20587743-Prospective Studies
|
|
pubmed:articleTitle |
Identifying optimal initial infusion rates for unfractionated heparin in morbidly obese patients.
|
|
pubmed:affiliation |
Department of Pharmacy, Barnes-Jewish Hospital, St. Louis, MO 63110, USA. jnr0905@bjc.org
|
|
pubmed:publicationType |
Journal Article,
Controlled Clinical Trial
|
